Presentación Fundación IFRS 13

Embed Size (px)

Citation preview

  • 8/12/2019 Presentacin Fundacin IFRS 13

    1/79

  • 8/12/2019 Presentacin Fundacin IFRS 13

    2/79

    2Disclaimer and allowed useThis Microsoft PowerPoint presentation was prepared by IASB EducationInitiative staff as a convenience for others. It has not been approved by the IASB.

    The IFRS Foundation allows individuals and organisations to use thispresentation to conduct training, provided that copies of this presentation (or anypart of it) whether hard copy, electronic or otherwise are provided free of charge.If you require any other use please contact us. Any changes to this presentationmust be clearly identifiable as not part of the presentation prepared by the

    Education Initiative staff and the copyright notice must be removed from everyamended page.

    Disclaimer: The IFRS Foundation, the authors, the presenters and the publishersdo not accept responsibility for any loss caused by acting or refraining fromacting in reliance on the material in this presentation, whether such loss iscaused by negligence or otherwise. This presentation is intended as guidance

    only and does not constitute any type of advice. This presentation may be modified from time to time. To download the latestversion and to learn more about the IASB Education Initiative, visit:http://www.ifrs.org/Use-around-the-world/Education/Pages/Education.aspx

    IFRS Foundation

    http://www.ifrs.org/Use-around-the-world/Education/Pages/Education.aspxhttp://www.ifrs.org/Use-around-the-world/Education/Pages/Education.aspxhttp://www.ifrs.org/Use-around-the-world/Education/Pages/Education.aspxhttp://www.ifrs.org/Use-around-the-world/Education/Pages/Education.aspxhttp://www.ifrs.org/Use-around-the-world/Education/Pages/Education.aspxhttp://www.ifrs.org/Use-around-the-world/Education/Pages/Education.aspxhttp://www.ifrs.org/Use-around-the-world/Education/Pages/Education.aspxhttp://www.ifrs.org/Use-around-the-world/Education/Pages/Education.aspx
  • 8/12/2019 Presentacin Fundacin IFRS 13

    3/79

    Agenda Part I: context and scope

    Part II: measurement of fair value Part III: valuation approaches and techniques

    Part IV: disclosures

    Part V: effective date and transition

    3

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    4/79

    Part IContext and scope

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    5/79

    Part I: context and scope Why IFRS 13 is necessary

    Scope when IFRS 13 applies Scope what IFRS 13 does not apply to

    5

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    6/79

    Before IFRS 13 dispersed andconflicting guidance 6

    IAS 40IAS 39/IFRS 9 IAS 41IAS 36 Etc.

    IFRS 13

    Single source of measurement guidance Clear measurement objective Consistent and transparent disclosures about fair

    value

    Topic 820 in US GAAP (codified SFAS 157)

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    7/79

    The previous definition of fair value 7

    Fair value definition Its weaknesses

    The amount for which anasset could be

    exchanged or a liability settled

    between knowledgeable, willing parties in an arms

    length transaction.

    It did not specify whether an entityis buying or selling the asset

    ?

    It was unclear about what settling

    meant because it did not refer tothe creditor

    It was unclear about whether it wasmarket-based

    It did not state explicitly when theexchange or settlement takes place

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    8/79

    When does IFRS 13 apply?

    When another IFRS requires or permits fair valuemeasurements or disclosures about fair valuemeasurements

    IFRS 13 also applies to measurements, such as fair

    value less cost to sell, based on fair value ordisclosures about those measurements

    8

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    9/79

    When does IFRS 13 apply? 9

    For example, if you own a biological asset

    IAS 41 A biological asset shall be

    measured on initial recognition andat the end of each reporting period

    at its fair value less cost to sell

    IFRS 13

    What

    andwhen

    How

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    10/79

    What does IFRS 13 not apply to? 10

    Excluded from thescope

    IFRS 2 and IAS 17

    Disclosures in IFRS 13not required for

    Plan assets (IAS 19) Retirement benefit plan

    investments (IAS 26) Assets for which recoverable

    amount is fair value less costof disposal (IAS 36)

    Not required formeasurement similar tofair value

    IAS 2 (net realisable value) IAS 36 (value in use)

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    11/79

    Part IIMeasurement of fair value

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    12/79

    Part II: measurement of fair value Definition of fair value and measurement principles

    Considerations specific to non-financial assets Considerations specific to liabilities

    12

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    13/79

    Definition of fair value andmeasurement principles

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    14/79

    IFRS 13s new definition of fair value 14

    New fair value definition Comments

    the price that would bereceived to

    sell an asset or paid totransfer a liability in an

    orderly transactionbetween market

    participants at themeasurement date .

    It specifies that the entity is sellingthe asset

    It refers to the transfer of a liability

    It is clear it is market-based

    It states explicitly when the sale ortransfer takes place

    It is not a forced or distressed sale

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    15/79

    Fair value at initial recognition

    Transaction price (entry price) = Fair value(exit price) unless: Transaction takes place in different

    markets Transactions are for different units of

    account

    Seller is distressed or forced Transactions are between related parties

    15

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    16/79

    A hypothetical transaction price 16

    Marketparticipant

    buyer

    Marketparticipant

    seller

    Fair valueof

    Principal market (or mostadvantageous market)

    an asset

    a liabilit y

    at the

    measurementdate

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    17/79

    Who would transact for the item?

    Market participants are buyers and sellers in theprincipal (or most advantageous) market who are:

    Market participants act in their economic bestinterest

    Maximise the value of the asset Minimise the value of the liability

    17

    Independent Knowledgeable

    Able to enter into atransaction

    Willing to enter intoa transaction

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    18/79

    What is being measured?

    Unit of account IAS 41: A biological asset shall be measured at its fair value less costs to sell

    Characteristics Which characteristics would a market participant

    buyer take into account? age and remaining economic life condition

    location restrictions on use or sale contractual terms

    18

    IFRS Foundation

    Where would the transaction take

  • 8/12/2019 Presentacin Fundacin IFRS 13

    19/79

    Where would the transaction takeplace?

    In most cases, these markets will be the same

    arbitrage opportunities will be competed away The entity must have access to the principal (or most

    advantageous) market

    19

    Fair value is the price in the

    Principal market Or, if no principal market, themost advantageous market

    The market with the greatestvolume and level of activity forthe asset or liability

    The market that maximises theamount that would be received tosell the asset and minimises theamount that would be paid totransfer the liability

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    20/79

    Transaction and transport costs 20

    Description Included in fair value?

    Transactioncosts

    The costs to sell the assetor transfer the liability thatare directly attributable tothe disposal of the asset

    or the transfer of theliability

    No (Although they areconsidered in theassessment of whichmarket is most

    advantageous)They are a characteristic ofthe transaction, not of theasset or liability

    Transportcosts

    The costs that would beincurred to transport anasset from its currentlocation to its exit market

    Yes Transport changes acharacteristic of the asset(its location)

    IFRS Foundation

    How do we arrive at a market based

  • 8/12/2019 Presentacin Fundacin IFRS 13

    21/79

    How do we arrive at a market-basedmeasurement? 21

    Is there a quoted price in an active market for an identical asset or liability?

    Use this quoted price tomeasure fair value (Level 1)

    Replicate a market price through avaluation technique* (using observable +

    and unobservable inputs: Levels 2 and 3)

    No significantunobservable

    (Level 3) inputs =

    Level 2 measurement

    Use of significantunobservable

    (Level 3) inputs =

    Level 3 measurement

    Must use without adjustment

    Yes No

    * Valuation techniques include themarket approach, income approach

    and cost approach.+ Maximise the use of relevant observable inputs and minimise the use of unobservableinputs. Observable inputs include market data (prices and other information that is publiclyavailable). Unobservable inputs include the entitys own data (budgets, forecasts ), which must beadjusted if market participants would use different assumptions.

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    22/79

    Considerations specific to

    non-financial assets

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    23/79

    Highest and best use

    Fair value assumes a non-financial asset isused by market participants at its highest andbest use the use of a non-financial asset by market

    participants that maximises the value ofthe asset

    physically possible

    legally permissible financially feasible

    23

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    24/79

    Highest and best use continued

    Highest and best use is determined from theperspective of market participants, even if the entityintends a different use.

    However , an entitys current use of a non -financial

    asset is presumed to be its highest and best useunless market or other factors suggest that adifferent use by market participants would maximisethe value of the asset.

    24

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    25/79

    Highest and best use continued

    Highest and best use is usually (but not always) thecurrent use if for competitive reasons an entity does not

    intend to use the asset at its highest and best

    use, the fair value of the asset should still bemeasured assuming its highest and best use bymarket participants (defensive value)

    Does not apply to financial instruments or liabilities

    25

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    26/79

    Valuation premise A non-financial asset either:

    provides maximum value through its use in combinationwith other assets and liabilities as a group

    is its value influenced by it being operated with otherassets?

    an example: equipment used in production facility market participants are assumed to hold

    complementary assets provides maximum value through its use on a stand-alone

    basis

    is its value independent of its use with other assets? an example: a vehicle or an investment property

    Does not apply to financial instruments or liabilities

    26

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    27/79

    Considerations specific to liabilities

    IFRS Foundation

    Transfer notion liabilities and an

  • 8/12/2019 Presentacin Fundacin IFRS 13

    28/79

    Transfer notion liabilities and anentitys own equity instruments

    Fair value assumes a transfer to a marketparticipant who takes on the obligation. The transferassumes:

    28

    Liability or equity remains outstandingRestrictions on transfer are already reflected in

    inputs; no additional adjustment required

    Fair value of a liability reflects the effect ofnon-performance risk

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    29/79

    Decision tree liability measurement 29Is there an

    observable marketprice to transfer the

    instrument? Does somebody hold thecorresponding asset?

    Fair value =observable marketprice of instrument

    Fair value = fair value ofthe corresponding asset

    Is there an observablemarket price for the

    instrument traded as anasset?

    Fair value = anothervaluation

    technique*

    No Yes

    Yes No

    Yes

    Fair value =observable market

    price of asset

    No

    Fair value =another valuation

    technique

    * Using theperspective of amarket participant thatowes the liability orissued the claim onequity

    Level 2 or 3 IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    30/79

    No corresponding asset

    Two possible ways to approach it:

    1. Use the future cash flows that a market participantwould expect to incur in fulfilling the obligation ,including the compensation that a market

    participant would require for taking on theobligation. Such compensation includes: the cost to fulfil the obligation plus a return for

    undertaking the activity; and

    a risk premium to compensate for the risk thatactual cash flows might differ from expectedcash flows.

    30

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    31/79

    No corresponding asset continued

    2. Use the amount that a market participant wouldreceive to enter into or issue an identical liability orequity instrument.

    31

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    32/79

    Part IIIValuation approaches and

    techniques

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    33/79

    Part III: valuation techniques Valuation approaches

    Valuation techniques illustration for unquotedequity instruments

    Bid and ask spread, premiums and discounts

    Measuring the fair value of portfolios

    33

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    34/79

    Valuation approaches

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    35/79

  • 8/12/2019 Presentacin Fundacin IFRS 13

    36/79

    Valuation approaches continued

    Cost approach the cost to acquire or reconstruct a substitute

    asset of comparable utility, adjusted for physical,functional and economic obsolescence

    often used for PP&E and some intangibles Income approach

    converts future amounts (eg cash flows) to asingle current discounted amount, for example:

    present values option pricing models multi-period excess earnings method

    36

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    37/79

    Selecting a valuation approach 37

    L e v e

    l 2

    L e v e

    l 1

    L e v e

    l 3

    Market approachMarket price is available

    Price needsadjustment

    Observableinputs

    Price foridentical item

    Must be usedwithoutadjustment

    Cost approach(eg replacement cost)

    Income approach(eg discounted cash flow)

    Observableinputs

    Rare

    Observableinputs

    Rare

    Price needsadjustment

    Unobservableinputs

    Unobservableinputs

    Unobservableinputs

    Not directlyincome-producing

    No identical market price Price needs adjustment

    Directly identifiable cashflows

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    38/79

    Valuation techniques illustrationfor unquoted equity instruments

    IFRS Foundation

    Measuring the fair value of unquoted

  • 8/12/2019 Presentacin Fundacin IFRS 13

    39/79

    equity instruments

    Scope of this particular illustration:

    Unquoted equity instruments not quoted in anactive market

    Non-controlling interest within the scope of IFRS 9

    A range of valuation techniques can be used.

    Judgement is involved in the selection of a valuation technique (given

    specific facts and circumstances, some

    techniques might be more appropriate thanothers) when applying the valuation technique

    IFRS Foundation

    V l i h d h i

  • 8/12/2019 Presentacin Fundacin IFRS 13

    40/79

    Valuation approaches and techniquesValuationapproaches

    Valuation techniques

    Market approach Transaction price paid for an identical ora similar instrument of an investee

    Comparable company valuation multiples

    Income approach Discounted cash flow (DCF) method

    Dividend discount model (DDM)

    Constant-growth DDM

    Capitalisation model

    A combination ofapproaches may beused

    Adjusted net asset method

    40

    IFRS Foundation

    M k h

  • 8/12/2019 Presentacin Fundacin IFRS 13

    41/79

    Market approach Uses prices and other relevant information that have

    been generated by market transactions that involveidentical or comparable assets.

    Techniques that are most commonly referred to forvaluing unquoted equity instruments are related to the

    data sources that they use: transaction price paid for an identical or a similar

    instrument of an investee comparable company valuation multiples derived from

    quoted prices (ie trading multiples) or from prices paid intransactions such as mergers and acquisitions (ietransaction multiples)

    41

    IFRS Foundation

    V l ti lti l

  • 8/12/2019 Presentacin Fundacin IFRS 13

    42/79

    Valuation multiples

    Valuation basis: Equity value Enterprise value (EV)

    Multiple = ( )

    Performance measures: EBITDA, EBIT, EBITA Earnings, ie net income (E)

    Book value, ie value of an entitys shareholdersequity (B)

    Revenue

    42

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    43/79

    Commonly used valuation multiples

  • 8/12/2019 Presentacin Fundacin IFRS 13

    44/79

    Commonly used valuation multiples Earnings multiples commonly used when valuing:

    established business with an identifiable stream ofcontinuing and stable earnings:

    , , (where P is entitys market capitalisation)

    Book value multiples: where entities use their equitycapital bases to generate earnings (eg businessesthat have not yet generated positive earnings)

    Revenue multiples:

    44

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    45/79

    Example applying comparablecompany peers multiples ti d

  • 8/12/2019 Presentacin Fundacin IFRS 13

    46/79

    company peers multiples continued

    Step 1 Identify comparable peers

    The investor has selected six comparable publiccompany peers that operate in the same businessand geographical region as Entity J.

    Step 2 Select the performance measure that ismost relevant to assessing the value for the investee.

    The investor has chosen the EV/EBITDA multiple tovalue Entity J because there are differences in the

    capital structure and depreciation policies betweenEntity Js comparable company peers and Entity J.

    46

    IFRS Foundation

    Example applying comparablecompany peers multiples ti d

  • 8/12/2019 Presentacin Fundacin IFRS 13

    47/79

    company peers multiples continued

    Step 3 Apply valuation multiple to obtain fair value

    Trading multiples of the comparable public companypeers are:

    47

    Upon further analysis, these entities areconsidered comparable (ie similar risk,growth and cashflow-generating profiles

    IFRS Foundation

    Example applying comparablecompany peers multiples continued 48

  • 8/12/2019 Presentacin Fundacin IFRS 13

    48/79

    company peers multiples continuedStep 3 continued

    Investor selected average multiple (ie 8.5x)because it appropriately reflects Entity Jscharacteristics relative to its peers.

    = = 100 8.5 =850

    = @ =850 350 = 500

    48

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    49/79

    Example applying comparablecompany peers multiples continued 50

  • 8/12/2019 Presentacin Fundacin IFRS 13

    50/79

    company peers multiples continued

    Step 4 continued

    Discount for the lack of liquidity assessed tobe 30% on the basis of relevant studiesapplicable in the region and industry as well ason the specific facts and circumstances.

    Therefore = 500 1 0.3 = 350

    And the fair value of 5% non-controlling interestis CU17.5m (ie CU350m 0.05)

    50

    IFRS Foundation

    Income approach 51

  • 8/12/2019 Presentacin Fundacin IFRS 13

    51/79

    Income approach

    Income approach converts future amounts(eg cash flows) to a single current (iediscounted) amount. Discounted Cash Flow method (DCF)

    Dividend Discount Model (DDM) Constant growth DDM Capitalisation model

    51

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    52/79

    WACC: cost of debt capitalcomponent and computation 53

  • 8/12/2019 Presentacin Fundacin IFRS 13

    53/79

    component and computation

    = ( + ) ( 1 ) + ( + )

    Computing WACC requires cost of equity capitaland cost of debt capital ( , respectively) and

    market participants expectations of the investeeslong-term optimal capital structure

    There are a number of approaches for estimating Based on recent borrowings

    By reference to an actual or synthetic creditrating and default spread

    53

    IFRS Foundation

    WACC: cost of equity capitalcomponent 54

  • 8/12/2019 Presentacin Fundacin IFRS 13

    54/79

    component

    Cost of equity capital ( ) is often estimated usingCAPM:

    = +

    where:

    is the expected rate of return on a risk-free asset is the required market rate of return on a fully

    diversified portfolio

    is the measure of the systematic risk for theindividual shares

    54

    IFRS Foundation

    Example DCF method usingenterprise value 55

  • 8/12/2019 Presentacin Fundacin IFRS 13

    55/79

    p

    An investor has 5% non-controlling interest in EntityR.

    FCFF of Y 1 to Y 5 of CU100m and terminal valuefrom Y 5 onwards is CU1,121.8m (assumption:inflation is offset by market shrinkange, no growth innominal terms)

    WACC 8.9%

    Fair value of debt = CU240m

    Non-controlling interest discount CU8m

    Discount for the lack of liquidity CU4.09m

    55

    IFRS Foundation

    Example DCF method usingenterprise value continued 56

  • 8/12/2019 Presentacin Fundacin IFRS 13

    56/79

    p

    IFRS Foundation

    Example DCF method usingenterprise value continued 57

  • 8/12/2019 Presentacin Fundacin IFRS 13

    57/79

    p

    IFRS Foundation

    A combination of approaches adjusted net asset method 58

  • 8/12/2019 Presentacin Fundacin IFRS 13

    58/79

    j

    Involves deriving the fair value of an investees equity

    instruments by reference to the fair value of its assetsand liabilities (recognised and unrecognised).

    Appropriate for an investee whose value is mainlyderived from the holding of assets (rather than from

    deploying those assets as part of a broader business). Requires measurement of the fair value of the

    individual assets and liabilities.

    Non-controlling interest and liquidity discounts may beapplicable.

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    59/79

    Bid and ask spread,premiums and discounts

    IFRS Foundation

    Pricing within a bid-ask spread 60

  • 8/12/2019 Presentacin Fundacin IFRS 13

    60/79

    The price atwhich the dealerwill

    For an asset, thenon-dealerentitys

    For a liability, thenon-dealerentitys

    Bid price buy exit price entry price

    Ask (offer) price sell entry price exit price

    IFRS Foundation

    Pricing within a bid-ask spread continued 61

  • 8/12/2019 Presentacin Fundacin IFRS 13

    61/79

    If an asset or a liability measured at fair value has abid and an ask price, use the price within the bid-ask spread that is most representative of fair value

    Mid-market pricing or other pricing conventions canbe used as a practical expedient for fair valuemeasurements within a bid-ask spread if theseconventions do not contravene the principle

    IFRS Foundation

    Premiums and discounts 62

  • 8/12/2019 Presentacin Fundacin IFRS 13

    62/79

    Any premium or discount applied must beconsistent with:

    characteristics of asset or liability the unit of account in the IFRS requiring fair

    value

    No block discounts an adjustment to a quoted price for reduction

    that would occur if a market participant were to

    sell a large holding of assets or liabilities in oneor a few transactions

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    63/79

    Measuring the fair value ofportfolios

    IFRS Foundation

    64Portfolios of financial instruments

  • 8/12/2019 Presentacin Fundacin IFRS 13

    64/79

    IFRS 13 permits an entity to measure a group offinancial assets and financial liabilities on the basis ofthe net risk exposure to either market risks or creditrisks.

    This practice was already allowed in IAS 39/IFRS 9

    The exception was permitted because: derivatives often cannot be sold, but management

    can mitigate risk exposure by entering into anoffsetting position

    portfolio composition is entity-specific (depends onentitys risk preferences )

    IFRS Foundation

    Portfolios of financial instrumentscontinued 65

  • 8/12/2019 Presentacin Fundacin IFRS 13

    65/79

    Conditions that need to be met: Entity must have documented risk management strategy The entity provides information on the basis of the net risk

    exposure to key management personnel Only for portfolios of instruments measured at FV

    Accounting policy decision

    Does not affect presentation in IAS 32. Allocations shall be performed on a reasonable and

    consistent basis.

    Portfolio-level adjustments may need to be allocated to theunit of account for presentation purposes.

    IFRS Foundation

    66Portfolios of financial instrumentscontinued

  • 8/12/2019 Presentacin Fundacin IFRS 13

    66/79

    If there are offsetting market risks : can apply bid-ask spread to net open risk

    position offsetting risks must be substantially the same duration of instruments leading to exposure to

    market risk must be substantially the same

    Market risk: the risk that the price will fluctuatebecause of changes in market prices

    (currency risk, interest rate risk and otherprice risk).

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    67/79

  • 8/12/2019 Presentacin Fundacin IFRS 13

    68/79

    General 69

  • 8/12/2019 Presentacin Fundacin IFRS 13

    69/79

    Fair value at end of reporting period

    Level in hierarchy

    Transfers between levels

    Valuation techniques and inputs used If highest and best use is different from

    current use

    IFRS Foundation

    General continued 70

  • 8/12/2019 Presentacin Fundacin IFRS 13

    70/79

    Disclosures also required for unrecognisedamounts (ie that are only disclosed) oramounts recognised using a differentmeasure (eg amortised cost)

    eg financial asset at amortised cost, butIFRS 7 requires disclosure of assets fairvalue

    Quantitative disclosures in a table unlessanother format is better IFRS Foundation

    General continued 71Ill t ti E l 15 F i l t th d f th

  • 8/12/2019 Presentacin Fundacin IFRS 13

    71/79

    Illustrative Example 15 - Fair values at the end of thereporting period and level of the fair value hierarchy

    for recurring fair value measurements

    IFRS Foundation

    31/12/X9

    Quoted prices inactive markets

    for identicalassets

    (Level 1)

    Significant otherobservable

    inputs(Level 2)

    Significantunobservable

    inputs(Level 3)

    Total gains(losses)

    Recurring fair value measurements

    Trading equity securities (a) :Real estate industry 93 70 23 Oil and gas industry 45 45 Other 15 15

    Total trading equity securities 153 130 23

    Other equity securities (a) :Financial services industry 150 150 Healthcare industry 163 110 53 Energy industry 32 32 Private equity fund investments (b) 25 25 Other 15 15

    Total other equity securities 385 275 110

    (CU in millions)Fair value measurements at the end of the

    reporting period using

    Description

    General continued 72

  • 8/12/2019 Presentacin Fundacin IFRS 13

    72/79

    Non-recurring fair value measurements

    Assets held for sale (c) 26 26 (15) Total non-recurring fair value measurements 26 26 (15)

    (a) On the basis of its analysis of the nature, characteristics and risks of the securities, the entity has determined that presenting them byindustry is appropriate.(b) On the basis of its analysis of the nature, characteristics and risks of the investments, the entity has determined that presenting themas a single class is appropriate.(c) In accordance with IFRS 5, assets held for sale with a carrying amount of CU35 million were written down to their fair value of CU26million, less costs to sell of CU6 million (or CU20 million), resulting in a loss of CU15 million, which was included in profit or loss for theperiod.(Note: A similar table would be presented for liabilities unless another format is deemed more appropriate by the entity.)

    Illustrative Example 15 - Fair values at the end of thereporting period and level of the fair value hierarchyfor non- recurring fair value measurements

    IFRS Foundation

    More information about Level 3 73

  • 8/12/2019 Presentacin Fundacin IFRS 13

    73/79

    Quantitative disclosure of unobservableinputs and assumptions used

    Reconciliation of opening to closing balances

    Description of valuation process in place

    IFRS Foundation

    More information about Level 3 continued 74

  • 8/12/2019 Presentacin Fundacin IFRS 13

    74/79

    Sensitivity analysis: narrative discussion about sensitivity to changes

    in unobservable inputs, including inter-relationships between inputs that magnify ormitigate the effect on the measurement

    quantitative sensitivity analysis for financialinstruments

    More detail in determining classes

    IFRS Foundation

    More information about Level 3 continued 75Illustrative Example 17 Quantitative information

  • 8/12/2019 Presentacin Fundacin IFRS 13

    75/79

    Illustrative Example 17 Quantitative informationabout significant unobservable inputs used

    Quantitative information about fair value measurements using significant unobservable inputs (Level 3)(CU in millions)

    DescriptionFair value at

    31/12/X9 Valuation technique(s) Unobservable input Range (weighted average)

    Other equi ty securities:Healthcare industry 53 Discounted cash flow w eighted average cost of capital 7% - 16% (12.1%

    long-term revenue grow th rate 2% - 5% (4.2%)

    long-term pre-tax operating margin 3% - 20% (10.3%discount for lack of marketability(a) 5% - 20% (17%)control premium(a) 10% - 30% (20%)

    Market comparable companies EBITDA multiple(b) 10 - 13 (11.3)revenue multiple(b) 1.5 - 2.0 (1.7)

    discount for lack of marketability(a) 5% - 20% (17%)control premium(a) 10% - 30% (20%)

    Energy industry 32 Discounted cash flow w eighted average cost of capital 8% - 12% (11.1%long-term revenue grow th rate 3% - 5.5% (4.2%)

    long-term pre-tax operating margin 7.5% - 13% (9.2%

    discount for lack of marketability(a)

    5% - 20% (10%)control premium(a) 10% - 20% (12%)

    Market comparable companies EBITDA multiple(b) 6.5 - 12 (9.5)revenue multiple(b) 1.0 - 3.0 (2.0)

    discount for lack of marketability(a) 5% - 20% (10%)control premium(a) 10% - 20% (12%)

    Private equity fund investments 25 Net asset value (c) n/a n/a

    IFRS Foundation

    More information about Level 3 continued 76Illustrative Example 18 Valuation processes:

  • 8/12/2019 Presentacin Fundacin IFRS 13

    76/79

    An entity might disclose the following:(a) For the group within the entity that decides the entitys valuation policies andprocedures:

    its description; to whom that group reports; and the internal reporting procedures in place (eg whether and, if so, how pricing,

    risk management or audit committees discuss and assess the fair value

    measurements);(b) the frequency and methods for calibration, back testing and other testingprocedures of pricing models;(c) the process for analysing changes in fair value measurements from period toperiod;(d) how the entity determined that third-party information, such as broker quotes or

    pricing services, used in the fair value measurement was developed in accordancewith the IFRS; and(e) the methods used to develop and substantiate the unobservable inputs used ina fair value measurement.

    Illustrative Example 18 Valuation processes:

    IFRS Foundation

    More information about Level 3 continued 77Ill t ti E l 19 N ti di i b t

  • 8/12/2019 Presentacin Fundacin IFRS 13

    77/79

    Illustrative Example 19 Narrative discussion aboutsensitivity to changes in unobservable inputs:

    The significant unobservable inputs used in the fair valuemeasurement of the entitys residential mortgage -backedsecurities are prepayment rates, probability of default andloss severity in the event of default. Significant increases(decreases) in any of those inputs in isolation would resultin a significantly lower (higher) fair value measurement.Generally, a change in the assumption used for theprobability of default is accompanied by a directionally

    similar change in the assumption used for the lossseverity and a directionally opposite change in theassumption used for prepayment rates.

    IFRS Foundation

  • 8/12/2019 Presentacin Fundacin IFRS 13

    78/79

    Part V: Effective date and

    transition

    IFRS Foundation

    Effective date and transition 79

  • 8/12/2019 Presentacin Fundacin IFRS 13

    79/79

    Effective 1 January 2013

    Earlier application permitted Prospective application, no comparatives

    IFRS Foundation